Email Updates

You are here

HIV Vaccine

There is momentum and promise in the search for an HIV vaccine.

An effective preventive HIV vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an HIV vaccine would play a powerful role in ensuring the end to the AIDS epidemic.

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are pursuing groundbreaking research with number of vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital HIV vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

What We're Reading

On this Vaccine Awareness Day, we must acknowledge that the HIV vaccine research field is quickly approaching a critical crossroads. This past decade has been spent launching improved vaccine concepts and immune‐based strategies into trials. Despite these advances, a safe and durably effective HIV vaccine has eluded us. In this regard, we must evaluate the current state of the field and make appropriate adjustments to help speed us to our goal.

May 18, 2020
JIAS

An experimental vaccine seems to give monkeys extended protection from an HIV-like infection -- by "waking up" an arm of the immune system that vaccines normally do not. Experts cautioned that animal research often does not pan out in humans. The decades of work toward an HIV vaccine has been a clear example. But, researchers said, this vaccine works differently, targeting two "arms" of the immune system.

May 11, 2020
US News & World Report

The HIV Vaccine Trials Network (HVTN) has issued an update on the status of the major HIV vaccines trials in the face of the coronavirus pandemic. The extreme disruptions to and restrictions on everyday life that the new pandemic has caused have interrupted the clinical trials process around the world.

April 7, 2020
POZ
Subscribe to RSS - HIV Vaccine